antiPLA2R Positive clinical trials at UCSF

1 in progress, 0 open to eligible people

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
Sorry, in progress, not accepting new patients
This is an open-label, multicentre study to characterize the safety and efficacy of the human anti-CD38 antibody MOR202 in adult subjects with in Anti-PLA2R Antibody Positive Membranous Nephropathy (newly diagnosed/relapsed/refractory)
San Francisco, California and other locations

Last updated: August 23, 2022